Study guide

10.5 Standard Operating Procedures & Document Control

BCSCP Board Certified Sterile Compounding Pharmacist Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Exam Overview, USP Standards & CSP Categories

1.1 BCSCP Exam Format, Eligibility, Scoring & 2024 Content Outline 1.2 USP <797> Scope, Core Philosophy & Regulatory Framework 1.3 USP <797> Categories 1, 2, and 3 CSP Classification 1.4 Immediate-Use CSPs: The 4-Hour Rule and Its Conditions

2 Chapter 2: Facilities, Engineering Controls & Cleaning

2.1 Cleanroom Architecture & ISO Classifications 2.2 Primary Engineering Controls (PECs) & Laminar Airflow Dynamics 2.3 Segregated Compounding Areas (SCAs) & Containment SCAs (C-SCAs) 2.4 HVAC Engineering Controls, Pressure Differentials & Air Exchange 2.5 Equipment & Materials in Classified Areas Under Dynamic Conditions 2.6 Cleaning, Disinfecting, Sporicidal Agents & Sterile 70% IPA 2.7 Contingency Planning: Power, HVAC, Supply and Staffing Failures

3 Chapter 3: Environmental Monitoring & Facility Certification

3.1 Viable Airborne Microbial Monitoring 3.2 Total Airborne Non-Viable Particle Counting & Cleanroom Certification Standards 3.3 Surface Microbial Sampling: Contact Plates, Swabs, Incubation Protocols & Action Levels 3.4 Environmental Sampling Excursions, Trend Analysis, and Remediation Protocols

4 Chapter 4: Hand Hygiene, Garbing & Aseptic Technique

4.1 Hand Hygiene & Cleansing Protocols 4.2 Step-by-Step Garbing Sequence & Ante-Room Logistics 4.3 Direct Compounding Area (DCA) Aseptic Technique & First Air Integrity

5 Chapter 5: Beyond-Use Dating, Storage & Container Rules

5.1 Category 1 Beyond-Use Dating & Storage Limitations 5.2 Category 2 Beyond-Use Dating: Sterile vs. Nonsterile Starting Components 5.3 Category 3 Beyond-Use Dating: Requirements for Extended Dating (60/90/120 Days) 5.4 Container Types, Puncture Limits & Multi-Dose Container Rules

6 Chapter 6: Sterilization, Release Testing & Hazardous Drug Compounding

6.1 Terminal Sterilization vs. Sterilizing Filtration 6.2 Release Testing: Sterility (USP <71>), Endotoxin (USP <85>) & Particulates (USP <788>) 6.3 Container Closure Integrity Testing (CCIT) & Visual Inspection 6.4 USP <800> Hazardous Drug Compounding & Closed System Drug-Transfer Devices (CSTDs)

7 Chapter 7: Materials, Equipment & Compounding Workflow

7.1 Compounding Equipment & Technology: ACDs, Balances, Pumps & IV Workflow Systems 7.2 Compounding Supplies, Containers & Closures 7.3 Component Receipt, Storage & Material Transfer 7.4 Calibration, Verification, Validation & Maintenance of Equipment 7.5 Compounding Workflow: SOPs, Workflow Software, Production Queues & Labeling 7.6 Handling, Storing, Packaging, Transporting & Disposing of Finished CSPs

8 Chapter 8: Calculations, Osmolarity & Physicochemical Compatibility

8.1 Sterile Compounding Calculations: Millimoles, Milliequivalents, Osmolarity & Tonicity Adjustments 8.2 Physical and Chemical Incompatibilities: pH Effects, Salt Formations & Precipitation Mechanisms 8.3 Complex Admixture Compatibility: Calcium-Phosphate Solubility Curves & Parenteral Nutrition Dynamics

9 Chapter 9: Therapeutics, Administration & Patient Monitoring

9.1 Patient-Specific Parameters: Verifying CSP Orders 9.2 Special Administration Routes: Epidural, Intrathecal, Ophthalmic & Intravesical Sterile Preparations 9.3 Medication Delivery Devices, Home Infusion & Patient Education 9.4 High-Alert Sterile Medications, Pediatric/Neonatal Considerations & Extravasation Management 9.5 Therapeutic Drug Monitoring, Catheter-Related Bloodstream Infection (CRBSI) Prevention & Clinical Vigilance 9.6 Medication Adherence in Home and Outpatient Sterile Therapy 9.7 Interprofessional Care Coordination for Sterile Preparations

10 Chapter 10: Quality Management, Records & Personnel Competency

10.1 Master Formulation Records (MFR) vs. Compounding Records (CR) Requirements & Workflow 10.2 Personnel Training, Core Competency & Written Testing Requirements 10.3 Gloved Fingertip and Thumb Sampling (GFT) Testing Cadence, Pass/Fail Thresholds & Action Plans 10.4 Media-Fill Testing Protocols: Simulation Design, Incubation Parameters & Failure Investigations 10.5 Standard Operating Procedures & Document Control 10.6 Quality Assurance & Quality Control Programs 10.7 Inspection Methods, Self-Audits & Continuous Readiness 10.8 Literature Evaluation: Research Methods, Statistics & Stability Evidence

11 Chapter 11: Regulatory Oversight, Accreditation & Drug Supply Chain

11.1 Drug Quality and Security Act (DQSA) & FDA Section 503A Traditional Pharmacies vs. Section 503B Outsourcing Facilities 11.2 State Boards of Pharmacy, FDA Guidance & Inter-Agency Regulatory Jurisdictions 11.3 Drug Supply Chain Security Act (DSCSA), Component Qualification & Certificate of Analysis (CoA) Verification 11.4 CMS, The Joint Commission, CDC, ASPEN & ASHP: Standards Beyond USP and FDA

12 Chapter 12: Safety Management, Investigations, Recalls & Waste

12.1 Root Cause Analysis (RCA), CAPA Framework & Out-of-Specification (OOS) Investigations 12.2 Adverse Drug Event Reporting, FDA MedWatch Form 3500 & Product Recall Protocols 12.3 Occupational Safety, Hazardous Waste Disposal (RCRA / EPA) & Spill Clean-up Management

10.5 Standard Operating Procedures & Document Control

Key Takeaways Explain This Topic AI

USP <797> Section 17 requires written SOPs for the compounding process and its support activities, stating which CSP categories the facility prepares, and the designated person must make sure they are appropriate and followed.

The designated person reviews every SOP initially and at least every 12 months, documents the review, and is the only one who may change an SOP. Each change is documented and communicated, and staff should acknowledge it.

All personnel who compound or support compounding are trained on the SOPs, show competency in every procedure tied to their job, and are trained to recognize and report problems, deviations, failures and errors to the designated person.

USP <800> Section 17 separately requires hazardous-drug SOPs covering every situation where HDs are used, reviewed at least every 12 months by the designated person.

Good document control uses version numbers, effective dates, approval signatures, controlled copies, archived superseded versions and a link to training records.

Last updated: September 2026

10.5 Standard Operating Procedures & Document Control

Much of USP <797> is written as "as described in the facility's SOPs." The chapter sets minimum requirements, and the facility's SOPs turn them into the specific steps people follow each day. Inspectors therefore read SOPs first, then watch whether practice matches them. The BCSCP outline lists standard operating procedures as practice-management task 3B1.

USP <797> Section 17 requirements

Facilities that prepare CSPs must develop SOPs for the compounding process and other support activities .

The SOPs must state the types of CSPs prepared : Category 1, 2 and/or 3.

A designated person makes sure the SOPs are appropriate and implemented. That includes making sure personnel show competency in every procedure related to their job .

The designated person follows up to make sure corrective actions are taken when problems, deviations, failures or errors occur, and the corrective action is documented .

Everyone who performs or oversees compounding or support activities is trained on the SOPs. Compounding personnel are trained to recognize potential problems (with equipment, facilities, materials, people, process or testing) and to report them to the designated person.

SOPs are reviewed initially and at least every 12 months by the designated person to make sure they reflect current practice, and each review is documented .

Only a designated person may change an SOP , and the change must be documented. Revisions are communicated to everyone involved, and personnel should document that they acknowledged the change.

USP <800> Section 17 mirrors this for hazardous drugs. The entity keeps SOPs for safe HD handling in every situation where HDs are used . The designated person reviews them at least every 12 months and documents the review, and revisions are communicated to everyone who handles HDs.

SOPs the chapters explicitly call for

Area Examples of required SOP content

Scope and special practices Handling patient blood-derived materials (e.g., autologous serum); immediate-use CSP procedures

Personnel Written training program; training for restocking and cleaning staff; garbing order and garb storage; disinfection of reusable goggles and respirators; RABS glove changes

Facility Review of temperature and humidity readings; material movement and other risk areas

Certification and monitoring Particle sampling sites; the microbiological monitoring program (sampling-site diagram, collection procedures, frequency, sample size, timing relative to activity, action levels); incubator temperature monitoring

Cleaning Agents, frequencies, methods and locations; how long opened sterile agents may be used; documentation

Equipment and components Calibration, maintenance, cleaning and use of equipment; the airborne-particle process assessment; selection, receipt, evaluation, handling, storage and documentation of components

Sterilization Cycle parameters, loads, biological indicators and endotoxin challenge vials; training; verification schedule; equipment maintenance

Records and release Approval of MFR changes; release testing; investigation of visual defects; labeling procedures

Quality Roles in the QA program; recall of out-of-specification CSPs; complaint handling; adverse event reporting

  • Distribution Handling, storage, packaging and transport of CSPs; temperature logs
  • Anatomy of a good SOP
  • Title, number, version and effective date
  • Purpose and scope : what the SOP covers, and what it does not
  • Responsibilities : who performs each step, who verifies, who approves
  • Definitions of terms and abbreviations
  • Materials and equipment needed
  • Procedure : numbered steps, one action per step, with acceptance criteria and pictures where they help
  • Deviations : what to do and whom to notify when something goes wrong
  • Records : which forms or electronic records are completed
  • References : USP chapters, state rules, manufacturer instructions
  • Revision history and approval signatures

Write for the person doing the task. Use short sentences and specific numbers, such as "contact time 3 minutes" rather than "adequate contact time." Where timing matters, state it exactly.

Document control and change management

Controlled copies: Only current versions are in use. Superseded versions are archived and marked obsolete, so staff never follow an old procedure.

Change control: A proposed change is reviewed for its effect on training, equipment, validation, BUDs and other SOPs before approval. Examples include a new disinfectant, glove brand or ACD software version.

Training linkage: A new or revised SOP triggers training and a competency check before the affected people perform the task. Training records reference the SOP version.

Deviations: An unplanned deviation , where the SOP was not followed, is documented, investigated and closed with CAPA. A planned deviation is approved in advance for a specific, time-limited reason.

Electronic systems: Electronic SOPs and records need access controls and audit trails. Outsourcing facilities under CGMP must meet FDA's electronic records rules (21 CFR Part 11).

Why this is tested

Many inspection findings are really SOP findings: no SOP for a required activity, an SOP never reviewed within 12 months, a changed practice without a changed SOP, or staff never trained on the current version. A BCSCP must be able to connect a USP requirement to the SOP that puts it into practice.